Search by Drug Name or NDC
NDC 71610-0553-60 Loratadine 10 mg/1 Details
Loratadine 10 mg/1
Loratadine is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Aphena Pharma Solutions - Tennessee, LLC. The primary component is LORATADINE.
MedlinePlus Drug Summary
Loratadine is used to temporarily relieve the symptoms of hay fever (allergy to pollen, dust, or other substances in the air) and other allergies. These symptoms include sneezing, runny nose, and itchy eyes, nose, or throat. Loratadine is also used to treat itching and redness caused by hives. However, loratadine does not prevent hives or other allergic skin reactions. Loratadine is in a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms. Loratadine is also available in combination with pseudoephedrine (Sudafed, others). This monograph only includes information about the use of loratadine alone. If you are taking the loratadine and pseudoephedrine combination product, read the information on the package label or ask your doctor or pharmacist for more information.
Related Packages: 71610-0553-60Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Loratadine
Product Information
NDC | 71610-0553 |
---|---|
Product ID | 71610-553_41f27cca-3947-46da-8b3d-92dda6601e17 |
Associated GPIs | 41550030000320 |
GCN Sequence Number | 018698 |
GCN Sequence Number Description | loratadine TABLET 10 MG ORAL |
HIC3 | Z2Q |
HIC3 Description | ANTIHISTAMINES - 2ND GENERATION |
GCN | 60563 |
HICL Sequence Number | 007605 |
HICL Sequence Number Description | LORATADINE |
Brand/Generic | Generic |
Proprietary Name | Loratadine |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Loratadine |
Product Type | HUMAN OTC DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 10 |
Active Ingredient Units | mg/1 |
Substance Name | LORATADINE |
Labeler Name | Aphena Pharma Solutions - Tennessee, LLC |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA076301 |
Listing Certified Through | 2024-12-31 |
Package
Package Images

NDC 71610-0553-60 (71610055360)
NDC Package Code | 71610-553-60 |
---|---|
Billing NDC | 71610055360 |
Package | 90 TABLET in 1 BOTTLE, PLASTIC (71610-553-60) |
Marketing Start Date | 2021-05-04 |
NDC Exclude Flag | N |
Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL 96b51213-4f93-4e09-8da1-85b27bd3de9d Details
Uses
Warnings
Ask a doctor before use if you have
liver or kidney disease. Your doctor should determine if you need a different dose.
When using this product
do not take more than directed. Taking more than directed may cause drowsiness.
Directions
Other information
Repackaging Information
Please reference the How Supplied section listed above for a description of individual tablets. This drug product has been received by Aphena Pharma - TN in a manufacturer or distributor packaged configuration and repackaged in full compliance with all applicable cGMP regulations. The package configurations available from Aphena are listed below:
Count | 10 mg |
90 | 71610-553-60 |
Store between 20°-25°C (68°-77°F). See USP Controlled Room Temperature. Dispense in a tight light-resistant container as defined by USP. Keep this and all drugs out of the reach of children.
Repackaged by:
Cookeville, TN 38506
20210614JH
INGREDIENTS AND APPEARANCE
LORATADINE
loratadine tablet |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
Labeler - Aphena Pharma Solutions - Tennessee, LLC (128385585) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Aphena Pharma Solutions - Tennessee, LLC | 128385585 | REPACK(71610-553) |